Agomab to Participate in Upcoming Investor Conferences
Agomab Therapeutics (AGMB) will participate in several investor conferences in New York in September 2026, featuring fireside chats at multiple events.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Agomab Therapeutics (AGMB) will participate in several investor conferences in New York in September 2026, featuring fireside chats at multiple events.
The company plans to attend Citi's 2026 Biopharma Back to School Conference on September 10, the 2026 Cantor Global Healthcare Conference on September 11, the H.C. Wainwright 28th Annual Global Investment Conference on September 15, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 16.
Details
News Market Reaction – AGMB
On Sep 4, the first trading day after this news, AGMB closed 6.41% above the previous close. Our momentum scanner recorded 10 alerts for this stock that day. Relative volume reached 1.7x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 4 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Antwerp, Belgium, September 3, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming investor conferences:
- Citi's 2026 Biopharma Back to School Conference. Thursday, September 10, 2026 in New York, NY.
- 2026 Cantor Global Healthcare Conference. Fireside chat on Friday, September 11, 2026 at 8:00 AM ET in New York, NY.
- H.C. Wainwright 28th Annual Global Investment Conference. Fireside chat on Tuesday, September 15, 2026 at 2:00 PM ET in New York, NY.
- Morgan Stanley 24th Annual Global Healthcare Conference. Fireside chat on Wednesday, September 16, 2026 at 9:15 AM ET in New York, NY.
About Agomab
Agomab is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for fibro-inflammatory diseases with high unmet medical need. Agomab’s product candidates are designed to target established, potent pathways and utilize organ-restricted approaches, with the aim of increasing efficacy while minimizing safety liabilities. Fostering a culture of excellence, Agomab’s mission is to pioneer therapeutics that aim to resolve fibro-inflammation and restore organ function to enable people with these disorders to live fuller and healthier lives.
Contacts
Investors
Sofie Van Gijsel
VP of Investor Relations
E-Mail: sofie.vangijsel@agomab.com
Phone: +1 781 296 1143
Media
Gretchen Schweitzer
Trophic Communications
E-Mail: agomab@trophic.eu
Phone: +49 172 861 8540
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which investor conferences will Agomab Therapeutics (AGMB) attend in September 2026?
Agomab Therapeutics will attend four investor events in New York: Citi's 2026 Biopharma Back to School Conference, the 2026 Cantor Global Healthcare Conference, the H.C. Wainwright 28th Annual Global Investment Conference, and the Morgan Stanley 24th Annual Global Healthcare Conference.
When and where is Agomab Therapeutics (AGMB) attending Citi's 2026 Biopharma Back to School Conference?
Agomab Therapeutics plans to participate in Citi's 2026 Biopharma Back to School Conference on Thursday, September 10, 2026, in New York, NY. The company indicates this as one of its upcoming investor conference appearances.
What is the schedule for Agomab Therapeutics (AGMB) at the 2026 Cantor Global Healthcare Conference?
Agomab Therapeutics is scheduled for a fireside chat at the 2026 Cantor Global Healthcare Conference on Friday, September 11, 2026, at 8:00 AM ET in New York, NY.
When will Agomab Therapeutics (AGMB) present at the H.C. Wainwright 28th Annual Global Investment Conference?
Agomab Therapeutics is set for a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 2:00 PM ET in New York, NY.
What is Agomab Therapeutics' (AGMB) schedule at the Morgan Stanley 24th Annual Global Healthcare Conference?
Agomab Therapeutics plans a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026, at 9:15 AM ET in New York, NY.